The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters or search function to help find relevant consultations.
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (77)
- Therapeutic goods regulation (18)
- Prescription medicines (15)
- Over the counter (OTC) medicines (14)
- Legislation (12)
- Complementary medicines (11)
- Advisory bodies and committees (10)
- Non-prescription medicines (10)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Medical devices safety (4)
- Advertising (3)
- Biological medicines (3)
- Medicine safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Search
251 result(s) found, displaying 151 to 175
-
ConsultationThis consultation considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
ConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
ConsultationThrough a targeted consultation, the TGA invited views of a number of stakeholders on proposed options for process improvements
-
ConsultationThe TGA sought comments from interested parties on the proposed criteria, accompanying guidance and plans for monitoring of the supply of Schedule 3 (S3) Pharmacist only - Appendix M substances. Closing date: 1 April 2019
-
ConsultationThe TGA sought feedback on how personalised medical devices are regulated in Australia. Closing date: 31 March 2019
-
ConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 31 March 2019
-
ConsultationThe TGA sought feedback on how software, including Software as a Medical Device, is regulated in Australia. Closing date: 31 March 2019
-
ConsultationThe TGA is seeking comments from interested parties on Options for the Regulation of Faecal Microbiota Transplantation materials.
-
ConsultationWe seek your views on the proposed regulatory changes that would facilitate the adoption of the internationally harmonised principles for introduction of the UDI system in Australia. Closing date: 18 February 2019
-
Consultation: Potential reclassification of active medical devices for diagnosis and patient therapy
ConsultationThe TGA seeks comments on the extent to which a similar approach will be appropriate in the Australian regulatory context. Closing date: 18 February 2019 -
ConsultationThe TGA sought comments on the proposal to introduce new and amended definitions, and a revised scope of the products regulated as medical devices in Australia. Closing date: 18 February 2019
-
ConsultationThe TGA sought comments on the applicability and usefulness of the content contained in the draft regulatory guidance and information materials. Closing date: 14 February 2019
-
ConsultationInvitation to comment on proposed amendments to the Poisons Standard - ACCS, March 2019 (late addition to the published agenda). Closing date: 8 February 2019
-
ConsultationProposed Amendments to the Poisons Standard are now available for public comment. Closing date: 21 January 2019
-
ConsultationDiscussion paper outlining different approaches to access and safety controls for alkyl nitrites
-
ConsultationClosing date extended to 14 December 2018
-
ConsultationAdvisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'. Closing date 31 October 2018
-
ConsultationThe IMDRF sought comments on a proposed guidance document and two information documents
-
ConsultationThe IMDRF sought comments on a proposed document and its annexes
-
ConsultationInvitation to comment on proposed Poisons Standard amendments. Closing date: 28 September 2018
-
ConsultationThe IMDRF is seeking comments on a proposed guidance document
-
ConsultationThe TGA is seeking comments on the proposed guidance for the use of Boxed Warnings for prescription medicines. Closing date: 31 August 2018
-
ConsultationThe TGA sought comments on the proposed Schedule 3 substances to be added to Appendix H of the Poisons Standard to allow them to be advertised direct to consumers. Closing date 9 July 2018
-
ConsultationCarbendazim has been deferred from the June 2018 ACCS meeting at the applicant’s request.
-
ConsultationConsultation on options for a regulatory response to the potential misuse of prescribed Schedule 8 opioids in Australia